Gene: SUPT7L
Official Full Name: SPT7 like, STAGA complex subunit gammaprovided by HGNC
Gene Summary: SUPT7L is a protein subunit of the human STAGA complex (SPT3; (MIM 602947)/TAF9 (MIM 600822)/GCN5 (MIM 602301) acetyltransferase complex), which is a chromatin-modifying multiprotein complex (Martinez et al., 2001 [PubMed 11564863]).[supplied by OMIM, Apr 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO32527 | SUPT7L Knockout cell line (HeLa) | Human | SUPT7L | 1:3~1:6 | Negative | Online Inquiry |
KO32528 | SUPT7L Knockout cell line (HCT 116) | Human | SUPT7L | 1:2~1:4 | Negative | Online Inquiry |
KO32529 | SUPT7L Knockout cell line (HEK293) | Human | SUPT7L | 1:3~1:6 | Negative | Online Inquiry |
KO32530 | SUPT7L Knockout cell line (A549) | Human | SUPT7L | 1:3~1:4 | Negative | Online Inquiry |
The SUPT7L Gene Knockout Cell Lines represent a transformative tool in molecular biology, specifically designed to facilitate the study of the SUPT7L gene's functions and its impact on cellular processes. These engineered cell lines have undergone precise genetic modifications to disrupt the SUPT7L gene, thereby enabling researchers to assess the role of this gene in various biological contexts.
The primary function of these cell lines is to provide a platform for loss-of-function studies, allowing scientists to elucidate the mechanisms by which SUPT7L influences gene expression, RNA processing, and cellular stress responses. By employing CRISPR-Cas9 technology for the knockout process, these cell lines ensure high specificity and efficiency, minimizing off-target effects and enhancing the reliability of experimental outcomes.
The scientific importance of SUPT7L Gene Knockout Cell Lines is underscored by their applications in fundamental research, including the study of immunological pathways, cancer biology, and developmental processes. Their utility extends into clinical research, where understanding the implications of gene disruptions can contribute to novel therapeutic strategies and biomarker identification.
What sets our SUPT7L Gene Knockout Cell Lines apart from alternatives is their optimized genetic targeting, high-quality validation, and extensive characterizations, ensuring consistent performance across experiments. Unlike conventional approaches that may yield variable results, these cell lines offer reproducibility that is essential for robust scientific inquiry.
Researchers and clinicians can leverage these knockout cell lines to gain deeper insights into SUPT7L-related diseases, potentially leading to breakthroughs in diagnostics and treatment options. Our commitment to rigorous quality control and validation has positioned us as a trusted provider in the field of genetic engineering. We ensure that every product, including the SUPT7L Gene Knockout Cell Lines, meets the highest scientific standards, enabling professionals to advance their research confidently.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.